Review Article
Impact of Ischemic Preconditioning on Outcome in Clinical Liver Surgery: A Systematic Review
Table 5
Outcome in clinical studies of ischemic preconditioning in orthotopic liver transplantation with subgroup analysis of hepatic steatosis.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ALT, alanine aminotransferase; AR, acute rejection; AST, aspartate aminotransferase; Bili, bilirubin; CR, chronic rejection; DBD, donation after brain death; GS, graft survival; Histo, histology; HS, hospital stay; ICU, intensive care unit stay; INR, international normalized ratio; IPC, ischemic preconditioning; LFT, liver function tests; MaS, macrovesicular steatosis; NS, no statistically significant difference according to the author; PT, prothrombin time; RCT, randomized control trial. 1Analyzed as group of marginal donor grafts (marginal donor defined as >15% MaS and/or age >65). |